Trials / Withdrawn
WithdrawnNCT01692912
Psoriatic Arthritis Treat to Target vs. Usual Care
A Trial of Active Psoriatic Arthritis (PsA): Randomizing to Treat to a Target vs. Usual Care
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Pope Research Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Canadian Rheumatologists will be randomized to treat their participants with active Psoriatic Arthritis to a target (disease activity score \<2.6), or as per their routine care. The aim of this study is to determine whether treating to a target results in greater disease improvement than treating patients using routine care.
Detailed description
Canadian Rheumatologists will be randomized to treat their participants with active Psoriatic Arthritis to a target (disease activity score \<2.6), or as per their routine care. The aim of this study is to determine whether treating to a target results in greater disease improvement than treating patients using routine care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Intensive Care | Rheumatologist aims to treat participant in order to achieve a disease activity score improvement of DAS28\<2.6 |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2014-11-01
- Completion
- 2014-11-01
- First posted
- 2012-09-25
- Last updated
- 2017-04-07
Locations
4 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT01692912. Inclusion in this directory is not an endorsement.